You are required to be logged in to access the full website
Click here if you have forgotten your username or password
19 February 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Thursday that the European Medicines Agency has validated a Type II variation application for Enhertu (trastuzumab deruxtecan) as monotherapy for adults with...
19 February 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Thursday reported positive second-season results from the Phase 3 SMART trial evaluating Enflonsia (clesrovimab) in infants and chi...
19 February 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) on Thursday announced a new agreement with Shreeji Imaging and Diagnostic Centre Pvt Ltd, an Indian manufacturer and distributor of f...
19 February 2026 - US-based AVEO Oncology, an LG Chem (KRX:051910) company, announced on Wednesday that the 20mg/kg dose of ficlatuzumab has been chosen for the combination arm of the Phase 3 registrational FIERCE-HN clinical trial following the plan...
19 February 2026 - Cedar Health Research, a Texas-based clinical trial network focused on underserved patients, and Texas Native Health, a Dallas nonprofit serving American Indian and Alaska Native communities, announced on Wednesday that they have o...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe